337 related articles for article (PubMed ID: 26830055)
21. Recent clinical trials of iodixanol.
Erdogan A; Davidson CJ
Rev Cardiovasc Med; 2003; 4 Suppl 5():S43-50. PubMed ID: 14668709
[TBL] [Abstract][Full Text] [Related]
22. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
23. Renal safety of iodixanol.
McCullough PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
[TBL] [Abstract][Full Text] [Related]
24. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
25. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
[TBL] [Abstract][Full Text] [Related]
26. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
[TBL] [Abstract][Full Text] [Related]
27. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials.
Pandya B; Chalhoub JM; Parikh V; Gaddam S; Spagnola J; El-Sayegh S; Bogin M; Kandov R; Lafferty J; Bangalore S
Int J Cardiol; 2017 Feb; 228():137-144. PubMed ID: 27863354
[TBL] [Abstract][Full Text] [Related]
28. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
[TBL] [Abstract][Full Text] [Related]
29. Contrast-induced nephropathy-choice of contrast agents to reduce renal risk.
Katholi RE
Am Heart Hosp J; 2009; 7(1):45-9. PubMed ID: 19742433
[TBL] [Abstract][Full Text] [Related]
30. Patient discomfort associated with the use of intra-arterial iodinated contrast media: a meta-analysis of comparative randomized controlled trials.
McCullough PA; Capasso P
BMC Med Imaging; 2011 May; 11():12. PubMed ID: 21609484
[TBL] [Abstract][Full Text] [Related]
31. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
[TBL] [Abstract][Full Text] [Related]
32. The relative renal safety of iodixanol compared with low-osmolar contrast media.
Cantor E; Lim L
JACC Cardiovasc Interv; 2009 Nov; 2(11):1163-4; author reply 1164. PubMed ID: 19926063
[No Abstract] [Full Text] [Related]
33. Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
Freitas RAP; Tanajura LF; Mehran R; Chamié D; Chaves A; Centemero M; Braga S; Costa R; Cao D; Sousa A; Feres F; Costa JR
J Invasive Cardiol; 2023 Jun; 35(6):E281-E290. PubMed ID: 37220640
[TBL] [Abstract][Full Text] [Related]
34. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media.
Spinler SA; Goldfarb S
Ann Pharmacother; 1992 Jan; 26(1):56-64. PubMed ID: 1606346
[TBL] [Abstract][Full Text] [Related]
35. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Bagshaw SM; Ghali WA
Arch Intern Med; 2005 May; 165(10):1087-93. PubMed ID: 15911721
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of intravenous iodinated contrast media in Italy.
Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M
Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022
[TBL] [Abstract][Full Text] [Related]
37. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
38. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
[TBL] [Abstract][Full Text] [Related]
39. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials.
Dong M; Jiao Z; Liu T; Guo F; Li G
J Nephrol; 2012; 25(3):290-301. PubMed ID: 22252847
[TBL] [Abstract][Full Text] [Related]
40. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
